Dwight Owen
Clinical trials sponsored by Dwight Owen, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for advanced lung cancer: drug combo trial launches Results expected Dec 2026 (estimated)
-
Experimental combo targets Hard-to-Treat lung cancer
Disease control PausedThis early-phase trial is testing whether combining two drugs—vismodegib and atezolizumab—is safe and tolerable for people with advanced non-small cell lung cancer that has returned or spread. Vismodegib blocks certain enzymes that help cancer cells grow, while atezolizumab helps…
Phase 1 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
New drug combo shows promise for rare thymic cancer
Disease control OngoingThis study tested a combination of two drugs, pembrolizumab and sunitinib, in 9 people with advanced thymic cancer that had spread or could not be removed and had stopped responding to standard chemotherapy. The goal was to see if the combination could shrink tumors or stop them …
Phase 2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC